HLA restriction of carbamazepine-specific T-cell clones from an HLA-A*31:01-positive hypersensitive patient

Chemical Research in Toxicology

Volumn 27, Issue 2, 2014, Pages 175-177

  Lichtenfels, Maike ^a   Farrell, John ^a   Ogese, Monday O ^a   Bell, Catherine C ^a   Eckle, Sidonia ^b   McCluskey, James ^b   Park, B Kevin ^a   Alfirevic, Ana ^a   Naisbitt, Dean J ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-PRESENTING CELLS; CARBAMAZEPINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; DRUG HYPERSENSITIVITY; HLA-A ANTIGENS; HUMANS;

EID: 84894266127     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx400460w     Document Type: Article

References (8)

1. Hung, S. I., Chung, W. H., Jee, S. H., Chen, W. C., Chang, Y. T., Lee, W. R., Hu, S. L., Wu, M. T., Chen, G. S., Wong, T. W., Hsiao, P. F., Chen, W. H., Shih, H. Y., Fang, W. H., Wei, C. Y., Lou, Y. H., Huang, Y. L., Lin, J. J., and Chen, Y. T. (2006) Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet. Genomics 16, 297-306
2. Wei, C. Y., Chung, W. H., Huang, H. W., Chen, Y. T., and Hung, S. I. (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome J. Allergy Clin. Immunol. 129, 1562-1569.e5
3. Ko, T. M., Chung, W. H., Wei, C. Y., Shih, H. Y., Chen, J. K., Lin, C. H., Chen, Y. T., and Hung, S. I. (2011) Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome J. Allergy Clin. Immunol. 128, 1266-1276.e11
4. McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperaviciute, D., Carrington, M., Sills, G. J., Marson, T., Jia, X., de Bakker, P. I., Chinthapalli, K., Molokhia, M., Johnson, M. R., O'Connor, G. D., Chaila, E., Alhusaini, S., Shianna, K. V., Radtke, R. A., Heinzen, E. L., Walley, N., Pandolfo, M., Pichler, W., Park, B. K., Depondt, C., Sisodiya, S. M., Goldstein, D. B., Deloukas, P., Delanty, N., Cavalleri, G. L., and Pirmohamed, M. (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans N. Engl. J. Med. 364, 1134-1143
5. Ozeki, T., Mushiroda, T., Yowang, A., Takahashi, A., Kubo, M., Shirakata, Y., Ikezawa, Z., Iijima, M., Shiohara, T., Hashimoto, K., Kamatani, N., and Nakamura, Y. (2011) Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population Hum. Mol. Genet. 20, 1034-1041
6. Niihara, H., Kakamu, T., Fujita, Y., Kaneko, S., and Morita, E. (2012) HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population J. Dermatol. 39, 594-601
7. Wu, Y., Farrell, J., Pirmohamed, M., Park, B. K., and Naisbitt, D. J. (2007) Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity J. Allergy Clin. Immunol. 119, 973-981
8. Illing, P. T., Vivian, J. P., Dudek, N. L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J. J., Kjer-Nielsen, L., Gras, S., Williamson, N. A., Burrows, S. R., Purcell, A. W., Rossjohn, J., and McCluskey, J. (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire Nature 486, 554-558